Bruton's tyrosine kinase revealed as a negative regulator of Wnt-beta-catenin signaling.
Bruton's tyrosine kinase revealed as a negative regulator of Wnt-beta-catenin signaling.
复制标题
DOI:
10.1126/scisignal.2000230
复制
发表时间:
2009-05-26
影响因子:
7.3
通讯作者:
Moon RT
中科院分区:
文献类型:
--
作者:
James RG;Biechele TL;Conrad WH;Camp ND;Fass DM;Major MB;Sommer K;Yi X;Roberts BS;Cleary MA;Arthur WT;MacCoss M;Rawlings DJ;Haggarty SJ;Moon RT
Wnts are secreted ligands that activate several receptor-mediated signal transduction cascades. Homeostatic Wnt signaling through β-catenin is required in adults, because either elevation or attenuation of β-catenin function has been linked to diverse diseases. To contribute to the identification of both protein and pharmacological regulators of this pathway, we describe a combinatorial screen that merged data from a high-throughput screen of known bioactive compounds with an independent focused small interfering RNA screen. Each screen independently revealed Bruton’s tyrosine kinase (BTK) as an inhibitor of Wnt–β-catenin signaling. Loss of BTK function in human colorectal cancer cells, human B cells, zebrafish embryos, and cells derived from X-linked agammaglobulinemia patients with a mutant BTK gene resulted in elevated Wnt–β-catenin signaling, confirming that BTK acts as a negative regulator of this pathway. From affinity purification–mass spectrometry and biochemical binding studies, we found that BTK directly interacts with a nuclear component of Wnt–β-catenin signaling, CDC73. Further, we show that BTK increased the abundance of CDC73 in the absence of stimulation and that CDC73 acted as a repressor of β-catenin-mediated transcription in human colorectal cancer cells and B cells.